"We are excited to be able to bring Mylan and Biocon's biosimilar insulin glargine to Europe and Australia where millions of people are currently living with diabetes, and we are committed to continuing to bring high quality, more affordable biosimilar products to markets around the world...
International Brand Name NovoMix 30 (Australia, Israel); Novorapid (Israel) ▪Drug ClassAntidiabetic agents; Hypoglycemics ▪IndicationsDiabetes mellitus ▪MechanismStimulates peripheral glucose uptake, inhibits hepatic glucose production, inhibits adipocyte lipolysis, inhibits proteolysis, and enhances prote...
Mylan and Biocon Get Approvals for Biosimilar Insulin Glargine in Europe and Australia
However, clients should use only one brand of syringe for a given ruler; using the same ruler between different brands of syringes or different sized syringes is dangerous because the barrel diameters may be different. 2 5 6 R o o m p R a n d Table 3 Dosing protocol for glargine or ...